TIL · Instil Bio, Inc.

NasdaqHealthcareBiotechnology

Instil Bio Inc Is A Clinical-Stage Biopharmaceutical Company Focused On Developing A Cell Therapy Pipeline Of Autologous Tumor Infiltrating Lymphocyte, Or Til, Therapies For The Treatment Of Patients With Cancer. It Is Also Engaged In Developing A Novel Class Of Genetically Engineered Til Therapies Using Its Co-Stimulatory Antigen Receptor, Or Costar, Platform. Its Pipeline Includes Itil-306 Which Expresses A Costar Molecule Designed To Recognize, A Tumor-Associated Antigen That Is Expressed On Numerous Solid Tumors, Including Ovarian Cancer, Uterine Cancer, Nsclc, And Renal Cancer.

HealthcareNasdaqUSVery Low Float

FLOAT

2.5M

FREE FLOAT %

37%

SHARES O/S

6.8M

MARKET CAP

$39.6M

EXCHANGE

Nasdaq

COUNTRY

TIL Catalyst History

No catalysts recorded for TIL yet

Day Trader Sniper hasn't classified a publishable catalyst for TIL yet. New events appear here as they're scored.

Be early on the next TIL spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

TIL · Instil Bio, Inc.

TIL Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.